IFM Investors Pty Ltd Buys 725 Shares of Celsius Holdings, Inc. (NASDAQ:CELH)

IFM Investors Pty Ltd grew its stake in Celsius Holdings, Inc. (NASDAQ:CELH) by 2.2% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 33,969 shares of the company’s stock after acquiring an additional 725 shares during the period. IFM Investors Pty Ltd’s holdings in Celsius were worth $2,817,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of CELH. Vanguard Group Inc. grew its position in shares of Celsius by 183.6% during the 4th quarter. Vanguard Group Inc. now owns 13,746,472 shares of the company’s stock worth $749,458,000 after buying an additional 8,899,873 shares in the last quarter. Wellington Management Group LLP increased its position in Celsius by 212.2% during the 4th quarter. Wellington Management Group LLP now owns 3,393,586 shares of the company’s stock valued at $185,018,000 after purchasing an additional 2,306,598 shares during the period. Eagle Asset Management Inc. raised its holdings in shares of Celsius by 188.8% in the 4th quarter. Eagle Asset Management Inc. now owns 2,958,771 shares of the company’s stock valued at $161,312,000 after purchasing an additional 1,934,400 shares in the last quarter. Price T Rowe Associates Inc. MD raised its holdings in shares of Celsius by 424.9% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 2,793,210 shares of the company’s stock valued at $152,287,000 after purchasing an additional 2,261,046 shares in the last quarter. Finally, Capital International Investors boosted its stake in shares of Celsius by 200.0% during the fourth quarter. Capital International Investors now owns 2,632,977 shares of the company’s stock valued at $143,550,000 after purchasing an additional 1,755,318 shares in the last quarter. 60.95% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Celsius

In related news, CFO Jarrod Langhans sold 4,079 shares of the business’s stock in a transaction on Friday, April 19th. The shares were sold at an average price of $69.42, for a total value of $283,164.18. Following the completion of the transaction, the chief financial officer now directly owns 83,670 shares in the company, valued at approximately $5,808,371.40. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other Celsius news, major shareholder Dean Desantis sold 100,000 shares of the firm’s stock in a transaction that occurred on Wednesday, March 13th. The stock was sold at an average price of $95.75, for a total value of $9,575,000.00. Following the sale, the insider now directly owns 219,257 shares of the company’s stock, valued at $20,993,857.75. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CFO Jarrod Langhans sold 4,079 shares of the business’s stock in a transaction that occurred on Friday, April 19th. The shares were sold at an average price of $69.42, for a total value of $283,164.18. Following the completion of the sale, the chief financial officer now owns 83,670 shares of the company’s stock, valued at $5,808,371.40. The disclosure for this sale can be found here. Insiders have sold 652,319 shares of company stock valued at $43,575,475 in the last 90 days. 2.20% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of brokerages recently commented on CELH. Maxim Group boosted their price objective on shares of Celsius from $100.00 to $110.00 and gave the stock a “buy” rating in a research note on Monday, April 1st. Piper Sandler raised their price objective on Celsius from $76.00 to $90.00 and gave the company an “overweight” rating in a research report on Friday, March 1st. Stifel Europe increased their price target on shares of Celsius from $90.00 to $95.00 and gave the company a “buy” rating in a research report on Monday, March 18th. UBS Group boosted their price objective on shares of Celsius from $73.00 to $99.00 and gave the stock a “buy” rating in a research note on Friday, March 1st. Finally, Bank of America downgraded shares of Celsius from a “buy” rating to a “neutral” rating and set a $65.00 target price for the company. in a research note on Friday, January 19th. Two analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat, Celsius currently has an average rating of “Moderate Buy” and an average price target of $85.10.

Celsius Stock Performance

CELH stock traded up $1.52 during midday trading on Friday, reaching $73.16. The stock had a trading volume of 1,613,270 shares, compared to its average volume of 3,685,534. The firm has a fifty day simple moving average of $79.78 and a two-hundred day simple moving average of $64.82. The stock has a market cap of $16.90 billion, a PE ratio of 94.61, a P/E/G ratio of 2.09 and a beta of 1.86. Celsius Holdings, Inc. has a 52-week low of $29.92 and a 52-week high of $99.62.

Celsius (NASDAQ:CELH) last issued its earnings results on Thursday, February 29th. The company reported $0.17 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.16 by $0.01. The firm had revenue of $347.44 million during the quarter, compared to analysts’ expectations of $326.77 million. Celsius had a net margin of 17.21% and a return on equity of 131.58%. The firm’s revenue was up 95.2% compared to the same quarter last year. During the same quarter last year, the company posted $0.01 earnings per share. On average, sell-side analysts predict that Celsius Holdings, Inc. will post 1.09 EPS for the current fiscal year.

Celsius Company Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.